RCPath CPD accredited
Supported by an educational grant from bioMérieux
Co-presenters: Dr Dan Wootton – Aintree, Dr Kay Roy – London, Prof Jan De Waele – Belgium, Prof David Livermore – East Anglia
Chaired by: Professor Elizabeth Sapey, Birmingham
– – – – –
If you require a certificate of attendance, details of how to obtain will appear at the end of the webinar.
Please note that once you have completed your details on the form, the certificate will be generated so please be ready to download your certificate immediately. We would like to inform delegates that each time a certificate is generated, we will be notified with details.
If you have any problems creating or downloading your certificate please contact Esme Carruthers at firstname.lastname@example.org
Liz is a Professor of Acute and Respiratory Medicine at the University of Birmingham and a medical physician caring for patients at the University Hospitals Birmingham NHS Foundation Trust. Her research focuses on non-communicable inflammatory diseases associated with ageing, and the impact of pulmonary infection in an ageing host, from translational to data science. Liz is the Managing Director of the NIHR Clinical Research Facility in Birmingham, a state-of-the-art clinical research facility that has supported over 15,000 patient research visits in 2020 and is currently delivering >300 active studies. Liz is also the Director of PIONEER, the HDR-UK Hub in Acute Care, integrating data from traditionally siloed acute care healthcare providers, with an aim of transforming care provision in this area of critical need, and improving outcomes and choices for patients.
Dr Dan Wootton is a Senior Clinical Lecturer in Respiratory Infection at the Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool. He is also an Honorary Consultant Respiratory Physician at Liverpool University Hospitals NHS Foundation Trust.
His research interest is in the syndromes of pneumonia. His NIHR Doctoral Fellowship focussed on Recovery from Community Acquired Pneumonia, and his current NIHR Advanced fellowship investigates health economics and optimal design for trials of novel diagnostic strategies in Hospital Acquired Pneumonia.
Dr Kay Roy is a Consultant Respiratory Physician at University College London Hospitals NHS Trust. She has a particular interest in airway diseases and associated pulmonary infections, with a PhD in COPD.
In recent years, she has also been closely involved with the implementation of point-of-care testing for acute respiratory infections to facilitate early diagnosis and management both in the acute setting and the community.
Dr Roy is a member of the British Thoracic Society specialist advisory group on Pulmonary Infection.
Jan De Waele works as an intensivist at the Dept. of Critical Care Medicine of the Ghent University Hospital. His research activities currently focus on optimising antibiotic therapy in severely ill, infected patients to improve outcome and combat resistance development, with specific interest in PK/PD, therapeutic drug monitoring of antibiotics as well as antimicrobial stewardship. Prof. De Waele has authored or co-authored over 250 journal articles and book chapters. He serves as the Chair of the Research Committee of the European Society of Intensive Care Medicine and currently is Associate Editor at the Journal of Critical Care.
Prof. David Livermore gained his BSc in 1978 and PhD in 1983. He worked at the London Hospital Medical College from 1980 to ‘97 then joined the Public Health Laboratory Service (now Public Health England), becoming Director of its Antibiotic Resistance Monitoring and Reference Laboratory in 1998. In 2011 he was appointed Professor of Medical Microbiology at the University of East Anglia, where he remains. Until a partial retirement in 2018, he also had sessions supplied to Public Health England as its Lead on Antibiotic Resistance.
Prof. Livermore has a long track record of research and publication on the evolution and epidemiology of antibiotic resistance, particularly beta-lactamases. At PHE he tracked the rise of many emerging resistance types, from MRSA to carbapenemase producers. At UEA his work centres upon rapid detection of antibiotic resistance as a means to refining antibiotic stewardship. Prof. Livermore has edited for several journals and serves on the Government’s Antimicrobial Resistance & Healthcare Associated Infection Advisory Committee.
Outside work he walks: including, over 20 years, the entire 3500-mile perimeters of England and Wales.